Invest now
Caplin Point Laboratories Cash Flow Annual
BSE: 524742 | NSE: CAPLIPOINT | ISIN: INE475E01026 | Sector: Biotechnology & Drugs2,810.25 -32.55 (-1.14%)Updated : 04 Sep 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | 0.02 | 0.27 | -3.13 | 2.91 |
| Net Changein Cash | -105.27 | 60.75 | -38.86 | 26.80 |
| Cash Taxes Paid | 144.50 | 127.64 | 109.00 | 88.00 |
| Net Income/ Starting Line | 802.79 | 676.78 | 564.43 | 451.35 |
| Total Cash Dividends Paid | -45.61 | -37.99 | -34.17 | -30.32 |
| Changesin Working Capital | -253.47 | -249.92 | -248.44 | -191.75 |
| Cashfrom Operating Activities | 523.24 | 432.37 | 318.39 | 271.37 |
| Cash Interest Paid | 0.87 | 0.61 | 0.78 | 0.78 |
| Cashfrom Financing Activities | -46.46 | -38.32 | -38.07 | -28.17 |
| Issuance( Retirement)of Stock Net | 0.00 | 0.01 | 0.01 | 0.02 |
| Depreciation/ Depletion | 72.77 | 65.96 | 53.44 | 44.99 |
| Other Investing Cash Flow Items Total | -334.17 | -143.21 | -174.22 | -24.11 |
| Capital Expenditures | -248.13 | -191.52 | -145.82 | -193.47 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | 0.25 | 1.43 | 0.86 | 1.18 |
| Non- Cash Items | -98.85 | -60.45 | -51.04 | -33.22 |
| Financing Cash Flow Items | -0.87 | -0.61 | -0.78 | -0.78 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -582.30 | -334.73 | -320.04 | -217.58 |
*All figures in crores except per share values
Caplin Point Laboratories Quick Links
Caplin Point Laboratories Dividend Caplin Point Laboratories Bonus Caplin Point Laboratories News Caplin Point Laboratories AGM Caplin Point Laboratories Rights Caplin Point Laboratories Splits Caplin Point Laboratories Board Meetings Caplin Point Laboratories Key Metrics Caplin Point Laboratories Shareholdings Caplin Point Laboratories Profit Loss Caplin Point Laboratories Balance Sheet Caplin Point Laboratories Q1 Results Caplin Point Laboratories Q2 Results Caplin Point Laboratories Q3 Results Caplin Point Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,266.15+11.15(0.89%)
1,686.60+13.70(0.82%)
2,540.00+13.30(0.53%)
4,960.00-110.00 (-2.17%)
2,807.35-55.15 (-1.93%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.